Trial is supported by Phase 2 results showing significant improvement in overall survival in women with newly diagnosed advanced ovarian cancer Novel immunotherapy technology demonstrating ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Fujio Mitarai, Chairman and CEO of Canon Inc. From imaging and healthcare to advanced ...
Abstract: Low-power wide-area networks (LPWANs) are crucial for large-scale Internet of Things (IoT) applications, yet they face increasing demands for higher data rates, improved reliability, and ...
Continuous Phase Modulation (CPM) constitutes a family of constant-envelope digital modulation techniques in which symbol transitions occur with continuous phase trajectories. By maintaining a ...
Figure 1: Schematic of two-photon polymerization direct laser writing inside a liquid crystal director. Localized polymerization forms a rigid network that locks the liquid crystal director and ...
3-weekly docetaxel 75 mg/m2 vs 2-weekly docetaxel 50 mg/m2 in combination with darolutamide + ADT in patients with mHSPC: Subgroup analyses from the randomised phase 3 ARASAFE trial. This is an ASCO ...
The Food and Drug Administration has refused to start a review of Moderna's application for its experimental flu shot, the company said. It's another sign of the Trump administration's influence on ...
The US Food and Drug Administration has refused to accept an application from Moderna to review its first mRNA seasonal flu vaccine, the company said Tuesday, in another setback for the technology ...
Sanofi’s multiple sclerosis hopeful tolebrutinib faced dual setbacks on Monday, with a late-stage failure in one form of the disease and yet another regulatory setback in another. Sanofi reported a ...
Treatment of chronic lymphocytic leukemia (CLL) currently consists of two main approaches — continuous therapy with Bruton’s tyrosine kinase inhibitors and fixed-duration regimens combining venetoclax ...
BOSTON--(BUSINESS WIRE)--Corsera Health, Inc., leading the future of cardiovascular health through prediction and prevention, today announced the filing of a clinical trial notification (CTN) to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results